Charlotte P. Peters
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Gastrointestinal pathologist consensus of revised high-grade dysplasia in inflammatory bowel disease impacts the advanced neoplasia rate: a multicenter study.
Journal: European journal of gastroenterology & hepatology
Published: February 07, 2025
Endoscopic and surgical treatment outcomes of colitis-associated advanced colorectal neoplasia: a multicenter cohort study.
Journal: International journal of surgery (London, England)
Published: January 06, 2023
Quality of Surveillance Impacts the Colitis-Associated Advanced Neoplasia Risk: A Multicenter Case-Control Study.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: July 21, 2022
TNF-anti-TNF Immune Complexes Inhibit IL-12/IL-23 Secretion by Inflammatory Macrophages via an Fc-dependent Mechanism.
Journal: Journal of Crohn's & colitis
Published: January 29, 2018
Profoundly Expanded T-cell Clones in the Inflamed and Uninflamed Intestine of Patients With Crohn's Disease.
Journal: Journal of Crohn's & colitis
Published: July 19, 2016
Innate lymphoid cells in inflammatory bowel diseases.
Journal: Immunology letters
Published: May 04, 2015
miR-511-3p, embedded in the macrophage mannose receptor gene, contributes to intestinal inflammation.
Journal: Mucosal immunology
Published: January 29, 2015
Effects of infliximab retreatment after consecutive discontinuation of infliximab and adalimumab in refractory Crohn's disease.
Journal: Inflammatory bowel diseases
Published: January 01, 2014
Screening prior to biological therapy in Crohn's disease: adherence to guidelines and prevalence of infections. Results from a multicentre retrospective study.
Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: December 30, 2013
Adalimumab for Crohn's disease: long-term sustained benefit in a population-based cohort of 438 patients.
Journal: Journal of Crohn's & colitis
Published: October 11, 2013
Ten years of infliximab for Crohn's disease: outcome in 469 patients from 2 tertiary referral centers.
Journal: Inflammatory bowel diseases
Published: April 05, 2013
Last Updated: 09/26/2026